Latest stories on BIO
BIO-key selected by Middle East government institution
The Fly61 · neutralproduct/pr
BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions
GlobeNewswire63 · neutralproduct/pr
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
StockTitan50 · neutralearnings
BIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM Solution
GlobeNewswire58 · neutralproduct/pr
BIO-key registers to sell 1.24M shares of common stock for holders
The Fly28 · bearishgeneral
Teva, Samsung Bioepis expand strategic partnership to advance biosimilars
The Fly63 · neutralproduct/pr
Franklin Biotechnology Discovery Fund Q2 2026 Commentary
Seeking Alpha55 · neutralgeneral
RBC Capital reiterates Bio-Rad Labs stock rating on transformation outlook
Investing.com Analyst Ratings56 · neutralanalyst
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
GlobeNewswire63 · neutralproduct/pr
Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Seeking Alpha55 · neutralproduct/pr
Biosysen Sets Dilution Protections on HK$50 Million Convertible Bonds
TipRanks28 · bearishgeneral
Why This Biotech Crashed On Its Proposed $2.35 Billion Merger
Investors.com28 · bearishm&a
Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
StockTitan55 · neutralproduct/pr
Bio-Rad: Favorable Read-Across From Investor Event
Seeking Alpha63 · neutralanalyst
Bio-Rad Laboratories, Inc. (BIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Barron's52 · neutralgeneral
This Biotech Stock Got a Rare Double-Downgrade. Its Profitability Problem Just Got Worse.
Barron's28 · bearishanalyst
Biotech Stocks Are Booming. What This Top Fund Is Buying Now.
Barron's74 · bullishgeneral
S&P 500 Futures Decline in Premarket Trading; Bio-Rad Labs A, Fabrinet Lag
Barron's42 · neutralgeneral
Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
Yahoo Top48 · neutralgeneral
Changes to full-year guidance for BioMar
GlobeNewswire34 · bearishearnings
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
Yahoo Top67 · bullishearnings
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
The Motley Fool68 · bullishearnings
Bio-Rad price target raised to $390 from $370 at RBC Capital
The Fly61 · neutralanalyst
Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings